HZHongying Zhang

Hongying Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongying Zhang has a total of 154 co-authors. Here are the top co-authors by number of shared publications:

  • Xin He

    Department of Pathology West China Hospital Sichuan University Chengdu Sichuan China

    26 shared publications
  • Min Chen

    Department of Pathology, West China Hospital, Sichuan University, Guoxuexiang 37, Chengdu, 610041, Sichuan, China

    22 shared publications
  • Huijiao Chen

    Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China

    19 shared publications
  • Zhang Zhang

    Department of Pathology, West China Hospital Sichuan University Chengdu Sichuan China

    18 shared publications
  • Yan Qiu

    Department of Pathology West China Hospital Sichuan University Chengdu Sichuan China

    13 shared publications
  • Hong Bu

    Institute of Clinical Pathology, Key Laboratory of Transplantation Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University

    11 shared publications

Latest Publications

  • Open Access

    Hardware‐Attentive Programmable Fourier Ptychography Enables Task‐Adaptive Label‐Free Virtual Staining

    by Tianyue He, Wenyi Jing, Le Zhang, Qican Zhang, Tingdong Kou, Xin He, Yan Qiu, Yang Lu, Jian Cui, Yongfu Wen, et al.

    Virtual staining will enable fast and reagent‐free histological imaging toward accurate and consistent pathology diagnosis. However, most current developments rely on heuristic optical landmarks and blind reconstruction, which reduces interpretability, limits cross‐task adaptations, and prevents their ultimate clinical translations. Here, we introduce an interpretable Plain‐to‐Stain framework, “Task‐Adaptive Programmable Optics (TAPO)” that removes manual landmark selection by directly tying programmable optical control to task‐specific diagnostic objectives. The approach operates under specially modulated visible light, and the highly programmable imaging system decomposes each optical step to execute optics‐attention‐based reconstruction, leading to task‐adaptive multimodal optical encoding for virtual staining. We demonstrated that TAPO successfully passed rigorous validation across diverse tissue types (liver, lung), pathological states (normal, malignant), staining protocols (H&E, Masson's trichrome), magnifications (10×, 20×), and section‐thickness settings including routine 4 µm sections and moderately thicker 10 µm sections. Blinded assessments by a panel of board‐certified pathologists on multiple virtual slides showed that TAPO results had high clinical acceptance, especially in resolution, cytoplasmic clarity, and nuclear staining, and demonstrated considerable potential for clinical pathology practice.


  • Insights into Langerhans cell sarcoma: Focus on cutaneous Langerhans cell sarcoma

    by Yu Xiong, Weiping Liu, Wenyan Zhang, Hongying Zhang, Sha Zhao

    Aims: Langerhans cell sarcoma (LCS) is a rare malignant neoplasm that relatively frequently presents with primary cutaneous involvement. Owing to its extreme rarity, it is necessary to characterize the clinicopathological features of cutaneous LCS. Methods: We analysed the clinicopathological features of five cutaneous LCS cases from our institution and reviewed an additional 38 cutaneous LCS cases and 69 extracutaneous LCS cases from the literature. Results: In our patients, disease progression exceeded 3 years in four patients (4/5, 80%) who were diagnosed with progressed cutaneous LCS, while one (1/5, 20%) experienced rapid progression within 2 months and was diagnosed with de novo cutaneous LCS. Tumour cells were medium to large in size, with atypical mitotic figures, and nuclear pleomorphism was noted in the former four patients; round‐to‐ovoid nuclei were seen in the latter one patient. Eosinophils were sparse and observed in four patients (4/5, 80%). S100, CD1a and Langerin expression were not consistently diffuse, with Langerin expressed in de novo cutaneous LCS. The progressed cutaneous LCS cases exhibited higher rates of lymph node metastasis (56.25% vs. 0%; P = 0.021), a trend toward more frequent ulceration (43.75% vs. 0%; P = 0.067) and a higher Ki‐67 proliferation index ( P = 0.046). Compared with extracutaneous LCS cases, cutaneous LCS cases demonstrated a malignant transformation course (84.62% vs. 19.57%; P < 0.001) and tended to have a more favourable prognosis ( P = 0.077). Conclusions: We summarize the clinicopathological features of cutaneous LCS. Recognition plays a crucial role in preventing misdiagnosis and guiding appropriate treatment.

  • A series of extraskeletal myxoid chondrosarcomas with rare morphological and molecular variations

    by Xinyang Chen, Xin He, Ran Peng, Min Chen, Hongying Zhang

    Aims: Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma characterised by myxoid matrix, multilobular architecture, eosinophilic ovoid to short spindle cells arranged in cords, clusters or reticular patterns and NR4A3 gene rearrangement. However, some EMCs show morphological variations or non‐ EWSR1::NR4A3 fusion. We described herein five cases of variant EMCs. Methods and results: The five patients included two females and three males, aged 24–59 years (median: 49 years). The tumours were located in the dorsal region, buttock, thigh, paravertebral region and elbow, respectively. Grossly, the tumour sizes ranged from 4.0 to 16.0 cm (median: 6.5 cm) in greatest dimension. Morphological examination revealed tumours with varied growth patterns, including solid variants with eosinophilic proteinaceous fluid (n = 2), classic EMC morphology with rhabdoid cells (n = 1), a biphasic variant, composed of fibroblastic/myofibroblastic‐like cells and oval to short spindle‐shaped cells (n = 1), and a spindle‐cell morphology with a myxoid stroma and prominent haemorrhagic cystic spaces (n = 1). Immunohistochemically, all cases showed variable expression of CD117. Next‐generation sequencing (NGS) identified an EWSR1::NR4A3 fusion, a novel FUS::NR4A2 fusion, a novel ACTB::NR4A3 fusion, and two FUS::NR4A3 fusions. Follow‐up for all five patients showed no signs of local recurrence or distant metastasis. Conclusion: These five cases of EMC highlight the continuous morphological spectrum of this tumour, demonstrating significantly greater histological diversity than classically described. The identification of novel fusion partners further expands its genetic landscape.


  • A cellular epithelioid hemangioma of the liver harboring a novel FOS::BCAR3 fusion gene

    by Yang Lu, Xianzhen Cui, Xin He, Min Chen, Hongying Zhang

    Epithelioid hemangioma (EH) arising from the liver is extremely rare, and its cellular variant can easily lead to diagnostic difficulties. Here, we report a cellular EH of the liver in a 63-year-old man. Microscopically, the lesion was multinodular. Approximately 95% of areas displayed solid and sheet-like growth. It mainly consisted of proliferative epithelioid cells with eosinophilic cytoplasm containing intracytoplasmic vacuoles, admixed with a few eosinophils. Tumor cells were immunoreactive for FOS, CD31, ERG, and CD34, but negative for FOSB, CAMTA1, and TFE-3. Fluorescence in situ hybridization identified FOS gene rearrangement, while FOSB rearrangement, CAMTA1 rearrangement, and WWTR1::CAMTA1 gene fusion were not detected. Furthermore, next-generation sequencing and Sanger sequencing demonstrated a FOS::BCAR3 fusion. To the best of our knowledge, this is the first reported case of cellular EH involving the liver and featuring a novel FOS::BCAR3 fusion, thereby broadening the spectrum of clinicopathological and genetic characteristics in this entity.

  • EBV ‐associated smooth muscle tumour: a clinicopathological and genetic study of nine cases revealing heterogeneous immune statuses and novel pathogenic mutations

    by Wenyi Jing, Dan Ren, Yan Qiu, Sheng Qin, Ting Lan, Xin He, Hongying Zhang

    Aims: EBV‐associated smooth muscle tumour (EBV‐SMT) is a rare neoplasm, primarily affecting patients with HIV, post‐transplantation (PT), and congenital immunodeficiency (CI). Most EBV‐SMT cases were reported by case reports, and genetic analyses are limited. Herein, we describe nine patients with EBV‐SMTs to further expand the clinicopathological and genetic spectrum of EBV‐SMT. Methods and results: Nine patients with EBV‐SMTs were identified from 2008 to 2024, and next‐generation sequencing (NGS) was performed in six cases with available material. The study comprised four males and five females aged 9–60 years old, including two patients with HIV‐SMTs, two with PT‐SMTs, three with CI‐SMTs, one post‐immunosuppressive therapy patient, and one clinically immunocompetent patient. Tumours involved liver ( n = 7), adrenal gland ( n = 6), retroperitoneum ( n = 1) and cervical spinal canal ( n = 1). Histologically, eight cases showed characteristic interlacing fascicles of spindled cells with inflammatory cell infiltration. In one CI‐SMT case, the tumour cells exhibited epithelioid morphology in a whorled pattern with obvious atypia. All cases showed SMA and EBER positivity. NGS detected recurrent mutations in PIEZO1 (3/6), CYP2B6 (2/6), NQO1 (2/6), NSMCE3 (2/6), and PI4KA (2/6). Novel pathogenic mutations in MAGT1 and CARMIL2 were identified in two CI‐SMTs, with the MAGT1 mutation linked to a rare immunodeficiency XMEN disease, reported here for the first time. Conclusion: Our study reported nine EBV‐SMT cases from heterogeneous immune statuses, with identification of recurrent mutations and pathogenic mutations in some of these tumours, further expanding its clinicopathological and genetic spectrum. Our findings suggest that EBV‐SMT cannot be excluded in clinically immunocompetent patients, and further cytogenetic investigations are warranted.


  • Open Access

    Case Report: Intestinal metastasis from ALK-rearranged pulmonary pleomorphic carcinomas mimicking inflammatory myofibroblastic tumors

    by Changle Shi, Yan Qiu, Kang He, Yuli Li, Qingsong Wan, Jin Yao, Hongying Zhang

    Lung carcinomas usually spread to the liver, lungs, pleura, pericardium, adrenal glands, brain, and bones. Anaplastic lymphoma kinase gene (ALK) fusion occurs in approximately 5% of non-small cell lung cancer (NSCLC) cases and most frequently in adenocarcinoma. Here, we report a rare case of intestinal metastasis originating from pulmonary pleomorphic carcinoma in a 49-year-old male heavy smoker. At the local hospital, the patient was initially considered to have an ALK-positive intestinal tumor, leading to a differential diagnosis of inflammatory myofibroblastic tumor (IMT). Due to the tumor’s peculiar morphology (including epithelioid and spindle cell components), pathologists of the local hospital sent slides of the case to our hospital for further consultation. Immunohistochemical analysis revealed that the epithelioid and spindle neoplastic cells were positive for CK7, TTF1, and ALK-V. Fluorescence in situ hybridization (FISH) confirmed the presence of the echinoderm microtubule-associated protein-like 4 (EML4):: ALK fusion. Based on these findings, we established the final diagnosis as intestinal metastasis of ALK-positive pulmonary pleomorphic carcinoma. A subsequent enhanced CT scan of the chest revealed a 3.0 cm solid mass in the right upper lung, further supporting the diagnosis of intestinal metastasis originating from pulmonary pleomorphic carcinoma. In conclusion, this case exhibited highly unusual clinicopathological features that could easily lead to misdiagnosis as primary intestinal tumors with ALK rearrangement. Pathologists must know this possibility to ensure accurate diagnosis and appropriate management.


  • Pelvic spindle cell sarcomas harboring MEIS1::NCOA2 fusion and novel gene amplifications in 10q23-26 region: a potential predictor for tumor progression

    by Yu Gao, Yang Lu, Jian Cui, Xin He, Hongying Zhang

    MEIS1::NCOA1/2 fusion undifferentiated spindle cell sarcomas generally arise from genitourinary and gynecologic tracts and mostly exhibit low-grade malignancies according to limited cases. Here, we report two cases from pelvic cavities. Case 1 showed low-grade morphology of monotonous spindle cells with moderate atypia in short fascicular or storiform patterns, while case 2 exhibited marked atypia, brisk mitosis, and significant necrosis. Notably, both cases identified intracytoplasmic eosinophilic globules. Next-generation sequencing analysis observed MEIS1::NCOA2 rearrangements in both cases, but only case 2 detected additional 10q23-26 amplifications and CTNNB1 mutation (c.94G > T/p.D32Y). Case 1 developed twice local recurrences in 3 years, while case 2 metastasized to the liver and gastroduodenal interstice and died 7 months after intraabdominal surgery. To the best of our knowledge, it is the first report about MEIS1::NCOA2 fusion sarcoma with distant metastasis to the abdomen. The extra 10q23-26 amplifications and CTNNB1 mutation may indicate potential predictors for malignancy in this study.


  • Open Access

    CAMTA1-immunonegative epithelioid hemangioendotheliomas of the liver: a clinicopathological and molecular analysis of seven cases

    by Yang Nie, Wenyi Jing, Xuanxuan Zheng, Xin He, Min Chen, Hongying Zhang

    Background: Epithelioid hemangioendothelioma (EHE) is a rare malignant vascular tumor. Most EHEs (>90%) cases harbor WWTR1::CAMTA1 fusion gene, and CAMTA1 immunohistochemistry (IHC) is a highly sensitive and specific tool for EHE diagnosis. However, there exist CAMTA1-immunonegative cases, the majority of which harbor YAP1::TFE3 fusion, with a few cases having more rare fusions. Liver is one of the most common sites of EHE, where the CAMTA1 subtype dominates, and the other variants are extremely rare. Hence, we focused on the hepatic CAMTA1-immunonegative EHEs to analyze the clinicopathological and molecular features of these peculiar cases.Methods: The SNOMED search of the hospital pathology files between January 2016 to November 2023 identified 57 hepatic EHEs and 7 cases were CAMTA1-immunonegative. Fluorescence in situ hybridization (FISH), next generation sequencing (NGS) and Sanger sequencing were performed to identify the genetic change of the 7 cases.Results: This series included 3 females and 4 males, aged from 33 to 64 years. All the 7 cases were negative for CAMTA1 IHC. Four cases were positive for TFE3 IHC and exhibited YAP1::TFE3 fusion. Another 3 cases were also negative for TFE3, while WWTR1::CAMTA1 fusion were detected by NGS in 1 case and demonstrated by FISH in all the 3 cases. Morphologically, among the 4 TFE3 rearrangement cases, 3 cases showed the TFE3-sutype morphologic appearance, while the histology of 1 case was similar to that of CAMTA1- subtype. In the 3 CAMTA1-rearranged lesions, 2 cases had classic EHE morphology, and 1 case exhibited atypical histology, with higher atypia and well-formed vessels. Surgical resection was performed on five cases and two cases were biopsied and received chemotherapy. Follow-up information was available in 6 patients (median 46 months), including 4 patients were alive without disease and 2 patients were alive with disease.Conclusion: Our study reported 7 CAMTA1-immunonegative hepatic EHEs and most of them were TFE3-rearranged EHEs with morphology variation. Moreover, there does exist the CAMTA1-immunonegative but CAMTA1-rearranged EHE cases. Therefore, the diagnosis of EHE should be based on morphology, combined with CAMTA1 and TFE3 IHC, and if necessary, supplemented by genetic analysis including FISH and NGS, to establish correct diagnosis.


  • CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma

    by Xuanxuan Zheng, Xin He, Yang Lu, Chang Chen, Hongying Zhang

    CTNNB1 mutations play important roles in the development of soft tissue tumors, such as desmoid fibromatosis (DF), sinonasal tract angiofibroma, sinonasal glomangiopericytoma, intranodal palisaded myofibroblastoma, neuromuscular choristoma (NMC), and the recently reported pseudoendocrine sarcoma. Here, we report a unique hybrid soft tissue tumor with classic DF, unusual epithelioid component, and NMC in a 23-year-old female. The classic DF and NMC and the unusual epithelioid component and NMC were locally intermixed and closely related to each other. Immunohistochemically, the DF, unusual epithelioid component, and NMC exhibited nuclear positivity for β-catenin to varying degrees. More critically, all of the above components harbored identical CTNNB1 p.Ser45Pro missense mutations. To the best of our knowledge, this is the only reported CTNNB1 mutation-driven hybrid tumor with DF, unusual epithelioid component, and NMC. The present case further confirmed that CTNNB1-mutational soft tissue tumors are highly heterogeneous, but the morphological spectrum is wide and consecutive.